. Author manuscript; available in PMC: 2013 May 24.

Published in final edited form as: J Am Coll Cardiol. 2010 Aug 24;56(9):692–699. doi: 10.1016/j.jacc.2010.03.068

Table 4. Serious Adverse Events by Treatment Group at 12 weeks.

SAE Type (N=194)	Sertraline N=98	Placebo N=96	P-value
Cardiovascular, No. (%)	69 (35.6)^*	72 (37.1)^*	.79
Psychiatric^†	0 (0)^*	2 (1)^*	.16
Non-CV and Non-psychiatric	29 (14.9)^*	22 (11.3)^*	.30

Percentages are calculated from the total SAEs (using N=194 as the denominator)

^†

No attempted or completed suicide